Fig. 4.
Fig. 4. Growth of HSVB7.1 or HSVlac amplicon-transduced EL4 cells and parental EL4 cells injected contralaterally in C57BL/6 mice. EL4 cells were infected ex vivo at an estimated MOI of 1 with either HSVB7.1 (A; mice no. 1 through 5) or HSVlac virus (B; mice no. 6 through 10). Viable transduced EL4 cells (106) were implanted SC on one side of the hind limb of the C57BL/6 mice, and parental (nontransduced) EL4 cells (106 cells/per mouse) were implanted on the contralateral hind limb. Tumor diameter was measured and expressed in millimeters. Tumor size in individual animals is shown.

Growth of HSVB7.1 or HSVlac amplicon-transduced EL4 cells and parental EL4 cells injected contralaterally in C57BL/6 mice. EL4 cells were infected ex vivo at an estimated MOI of 1 with either HSVB7.1 (A; mice no. 1 through 5) or HSVlac virus (B; mice no. 6 through 10). Viable transduced EL4 cells (106) were implanted SC on one side of the hind limb of the C57BL/6 mice, and parental (nontransduced) EL4 cells (106 cells/per mouse) were implanted on the contralateral hind limb. Tumor diameter was measured and expressed in millimeters. Tumor size in individual animals is shown.

Close Modal

or Create an Account

Close Modal
Close Modal